CBD Incorporated, a Deleware corporation based in California, has been formed to capitalize on the exponentially growing cannabinoid-based products market by focusing on what the company believes to be the most promising compound in industrial hemp, Cannabidiol or CBD, a popular additive in dietary supplements and cosmetics. Currently one of the most clinically studied molecules in the world, CBD
is showing promising results in the treatment of a wide range of medical conditions from sleeplessness and depression, to the prevention of epileptic seizures, and there is growing evidence for CBD’s anti-cancer properties. It contains no THC and does not produce a high. Like hemp seed, hemp oil, and hemp textiles, CBD is legal in all fifty states. The popularity of CBD products is growing so quickly that consumers are willing to pay as much as twice the price for this “liquid gold” than they will pay for solid gold. (Gold is currently $45/gram, while CBD oil sells for upwards of $90/gram.) founder, Tapio Maki believes that CBD will be the single most profitable investment opportunity of the decade – a “liquid gold rush.”
CBD, Inc. intends to become a premier supplier of wholesale CBD to the supplement and cosmetic industries, as well as a leading licensor of cutting-edge CBD extraction technology. For information on CBD INC.’s stock offering, visit the company’s website at TheLiquidGoldMine.com.
